FULVESTRANT Zentiva 250 mg/5ml 2 ser pré 5 ml

7680682810017 CH-68281 L02BA03 07.16.2.

Active substances:

FULVESTRANT Zentiva 250 mg/5ml 2 ser pré 5 ml
FULVESTRANT Zentiva 250 mg/5ml 2 ser pré 5 ml
1 / 2
google

Details

Product number
6828101
CPT
-
Packaging group
2
Unit
Fertigspritze(n)
Composition
fulvestrantum 250 mg, alcohol benzylicus 500 mg, benzylis benzoas 750 mg, ethanolum 96 per centum 500 mg, ricini oleum raffinatum q.s. ad solutionem pro 5 ml, corresp. ethanolum 12.17 % V/V.

Articles (1)

Fulvestrant Zentiva 250 mg/5 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
28/01/2026
Professional SmPC
Français
28/01/2026
Professional SmPC
Italien
28/01/2026

Detailed composition

Substance Quantity Type Category
fulvestrantum
250.0 MG Substance Wirkstoff (Principe actif)
alcohol benzylicus
500.0 MG Substance HBESI
benzylis benzoas
750.0 MG Substance HBESI
ethanolum 96 per centum
500.0 MG Substance HBESI
ricini oleum raffinatum
- Substance HNIDK

Reimbursement information

Public price
CHF 329.05
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2021

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
68281
Drug name
Fulvestrant Zentiva, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L02BA03
Authorization status
Z
Dispensation category
B
First authorization
24/05/2021
Authorization expiration date
31/12/9999
IT number
07.16.2.
Domain
Human medicine
Field of application
Cytostatikum

Packaging details

Description (FR)
FULVESTRANT Zentiva 250 mg/5ml 2 ser pré 5 ml
Description (DE)
FULVESTRANT Zentiva 250 mg/5ml 2 Fertspr 5 ml
Market launch
24/05/2021
Narcotic (BTM)
No

Original drug

Faslodex, Injektionslösung
CHF 379.80
View original
Buy us a coffee Explore the data